The Effects of Bright White Light Therapy on Fatigue, Sleep, Distress, Depression and Anxiety in the Hospitalized Leukemia Patient
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 74
- Locations
- 2
- Primary Endpoint
- Level of fatigue
Study Overview
Brief Summary
This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in hospitalized leukemia patients. Bright white light therapy may help to control these symptoms, and information from this study may help doctors and nurses learn more about methods for decreasing these symptoms.
Detailed Description
PRIMARY OBJECTIVE:
I. To assess the efficacy of bright white light therapy (BWLT) on fatigue in patients diagnosed with leukemia during their hospitalization.
SECONDARY OBJECTIVES:
I. To assess the efficacy of BWLT on sleep disturbance in patients diagnosed with leukemia during their hospitalization.
I. To assess the efficacy of BWLT on anxiety in patients diagnosed with leukemia during their hospitalization.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Admitted to the Acute Leukemia Unit for an anticipated stay of 3 weeks or longer
- •English speaking
- •Able to comprehend and sign a consent form
- •Able to read and complete surveys
- •Alert and oriented
- •Without BWLT for seven days prior to initiating the trial
Exclusion Criteria
- •Current eye disorders which is defined as:
- •Iritis, uveitis, keratitis, cataract, glaucoma, macular degeneration, retinal detachment, or retinitis pigmentosa
- •Diagnosed bipolar disorder
- •Persons with pacemakers
- •The manufacturer of the BWLT unit used for this study mentions the light unit contains magnets
Outcomes
Primary Outcomes
Level of fatigue
Time Frame: Up to one month after discharge
Will be assessed by Patient-Reported Outcomes Measurement Information System (PROMIS)-Fatigue. Will fit a mixed model of fatigue as a function of time and group.
Secondary Outcomes
- Anxiety(Up to one month after discharge)
- Sleep disturbance(Up to one month after discharge)
- Distress(Up to one month after discharge)
- Depression(Up to one month after discharge)
Investigators
Shelly Brown
Principal Investigator
Ohio State University Comprehensive Cancer Center